2020
DOI: 10.1016/j.resconrec.2020.104753
|View full text |Cite
|
Sign up to set email alerts
|

Metrics for quantifying the circularity of bioplastics: The case of bio-based and biodegradable mulch films

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
30
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 50 publications
(30 citation statements)
references
References 20 publications
0
30
0
Order By: Relevance
“…The dwindling of fossil resources provides a strong drive to the development of bio-based products, while the possibility to mitigate environmental pollution or simplify organic waste collection are big motivations behind the development of biodegradable and compostable plastic products. Bioplastics already find applications on the market, particularly as packaging [ 4 , 5 , 6 , 7 ], carrier and compost bags [ 5 , 6 ]; they are also applied in the agriculture and horticulture sector [ 6 , 8 ], and in the automotive and electronic industry [ 6 , 9 ]. Furthermore, biodegradable polymers have been long applied in biomedicine [ 5 , 10 , 11 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The dwindling of fossil resources provides a strong drive to the development of bio-based products, while the possibility to mitigate environmental pollution or simplify organic waste collection are big motivations behind the development of biodegradable and compostable plastic products. Bioplastics already find applications on the market, particularly as packaging [ 4 , 5 , 6 , 7 ], carrier and compost bags [ 5 , 6 ]; they are also applied in the agriculture and horticulture sector [ 6 , 8 ], and in the automotive and electronic industry [ 6 , 9 ]. Furthermore, biodegradable polymers have been long applied in biomedicine [ 5 , 10 , 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…Still, the production of bio-based plastics is limited to one percent of the worldwide plastic production [ 7 , 12 ] and their adoption comes with uncertainties, as acknowledged in the EC Communication “A European Strategy for Plastics in a Circular Economy” [ 13 ]. This is exemplified by the research focused on bioplastics sustainability and [ 8 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 ] biodegradability [ 26 , 27 , 28 , 29 , 30 ], as well as the attention of media to the subject. Excluding the ample literature on biomedical applications, academic research has been focusing on the synthesis of bio-based polymers [ 31 , 32 ], on the life cycle assessment (LCA) of the production and end-of-life (EOL) [ 20 , 24 , 33 , 34 ] of different bioplastics, and biodegradation under different conditions [ 10 , 14 , 35 ].…”
Section: Introductionmentioning
confidence: 99%
“…Much research work has been carried out to develop new CRFs containing natural polymers, instead of synthetic polymers. The substitution of synthetic polymers derived from fossil sources with natural polymers is a current major environmental issue [3]. Although biodegradable polymers can be also synthesized from monomers obtained from the petrochemical industry, the consumption of chemicals from fossil sources is a major source of GHG emission.…”
Section: Introductionmentioning
confidence: 99%
“…This shortcoming is likely exacerbated for the circularity assessment of already manufactured products, in which case circularity improvements are limited to end-of-life strategies. MCI could adopt more advanced designs to address this aspect, similar to the efforts made to respond to some other limitations of this method [11,28], or be combined with other circularity indicators better suited to account for end-of-life management practices and secondary material quality [10,[29][30][31][32][33][34][35][36]. Multiple circularity indicators have been developed exclusively to support end-of-life management practices and secondary material quality that could be used to complement MCI given some additional data of end-of-life procedures, material pricing or market potential [10,[29][30][31][32][33][34][35].…”
Section: Opportunities and Limitations Of The New Comparative Approach And Potential Implications For MCI Use And Developmentmentioning
confidence: 99%